ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,526.67
1.01%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Adma Biologics Inc (ADMA)

  7. Adma Biologics Inc (ADMA) 뉴스

ADMA

Adma Biologics (ADMA)

Adma Biologics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ADMA
일자시간출처헤드라인심볼기업
2024/05/0220:00GlobeNewswire Inc.ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:ADMAAdma Biologics Inc
2024/03/1205:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
2024/03/1201:19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADMAAdma Biologics Inc
2024/03/1120:00GlobeNewswire Inc.ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®NASDAQ:ADMAAdma Biologics Inc
2024/03/0911:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
2024/03/0606:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
2024/03/0521:00GlobeNewswire Inc.ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceNASDAQ:ADMAAdma Biologics Inc
2024/03/0511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
2024/02/2911:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
2024/02/2911:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
2024/02/2911:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
2024/02/2911:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
2024/02/2911:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
2024/02/2911:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
2024/02/2906:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
2024/02/2906:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
2024/02/2906:10GlobeNewswire Inc.ADMA Biologics Announces CFO TransitionNASDAQ:ADMAAdma Biologics Inc
2024/02/2906:05GlobeNewswire Inc.ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
2024/02/2811:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
2024/02/2206:05GlobeNewswire Inc.ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:ADMAAdma Biologics Inc
2024/02/2122:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
2024/02/2121:00GlobeNewswire Inc.ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsNASDAQ:ADMAAdma Biologics Inc
2024/02/1501:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMAAdma Biologics Inc
2024/01/0822:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
2024/01/0821:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
2024/01/0821:00GlobeNewswire Inc.ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
2024/01/0611:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
2023/12/1906:05GlobeNewswire Inc.ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares ManagementNASDAQ:ADMAAdma Biologics Inc
2023/12/1306:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
2023/12/1221:00GlobeNewswire Inc.ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and OlderNASDAQ:ADMAAdma Biologics Inc
 검색 관련기사 보기:NASDAQ:ADMA

최근 히스토리

USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
NYSE
CVX
Chevron
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
XOM
Exxon Mobil
USI
USTECH100
US Tech 100
FX
USDJPY
US Dollar vs Yen
NYSE
NKE
Nike
FX
USDEUR
US Dollar vs Euro
CCOM
US30
US 30
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
AMEX
XLV
Health Care Select Sector
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유